Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 21

Sort by

Sort Order Select

Journal Articles

Comparative Results of Pediatric Patients with ALL Receiving Either of Two Different Types of Human Anti-T Lymphocyte Globulin Prior to Hematopoietic Stem Cell Transplantation: Findings from the International Prospective Forum Study

Blood (2024) 144 (Supplement 1): 4864.

https://doi.org/10.1182/blood-2024-203358

Published: 2024

Journal Articles

Efficacy of T-cell assays for the diagnosis of primary defects in cytotoxic lymphocyte exocytosis

Blood (2024) 144 (8): 873–887.

https://doi.org/10.1182/blood.2024024499

Published: 2024

Includes: Supplemental data

Journal Articles

Outcomes of HLA-mismatched HSCT with TCRαβ/CD19 depletion or post-HSCT cyclophosphamide for inborn errors of immunity

Blood (2024) 144 (5): 565–580.

https://doi.org/10.1182/blood.2024024038

Published: 2024

Includes: Supplemental data

Journal Articles

Survival in primary hemophagocytic lymphohistiocytosis, 2016 to 2021: etoposide is better than its reputation

Blood (2024) 143 (10): 872–881.

https://doi.org/10.1182/blood.2023022281

Published: 2024

Includes: Supplemental data

Journal Articles

Comparable Outcome after Busulfan- or Treosulfan-Based Conditioning Regimen in Children Above 4 Years of Age with ALL Undergoing Allogeneic HSCT. Results from the Prospective International Forum-Trial

Krzysztof Kalwak, Peter Bader, Jean-Hugues Dalle, Petr Sedlacek, Jochen Buechner, Marianne Ifversen, Peter Svec, Jerry Stein, Tayfun Güngör, Jacek Toporski, Cristina Diaz De Heredia, Marc Bierings, Roland Meisel, Marc Ansari, Adriana Balduzzi, Ulrike Poetschger, Dr. Peters, Franco Locatelli

Blood (2023) 142 (Supplement 1): 232.

https://doi.org/10.1182/blood-2023-180728

Published: 2023

Journal Articles

Moderate Incidence but Striking Correlation with TBI of Secondary Malignancies after HSCT in Children with ALL: Long-Term Follow-up from the Prospective International BFM- and Forum-Trials

Anita Lawitschka, Jean-Hugues Dalle, Ulrike Pötschger, Helga Arnardottir, Petr Sedlacek, Jochen Büchner, Marianne Ifversen, Peter Svec, Jerry Stein, Tayfun Güngör, Jacek Toporski, Cristina Díaz De Heredia, Marc Bierings, Roland Meisel, Marc Ansari, Adriana Balduzzi, Franco Locatelli, Christina Peters, Peter Bader

Blood (2023) 142 (Supplement 1): 110.

https://doi.org/10.1182/blood-2023-186850

Published: 2023

Journal Articles

Outcome of Children with B-Cell Precursor Acute Lymphoblastic Leukemia (BCP-ALL) with Hypodiploidy or BCR-ABL1 Fusion Given Allogeneic Hematopoietic Stem Cell Transplantation (HSCT): Results from the Prospective Forum Study

Blood (2023) 142 (Supplement 1): 1050.

https://doi.org/10.1182/blood-2023-187587

Published: 2023

Journal Articles

Similar Overall Survival and Event-Free Survival for Patients Under or over the Age of 14 Years, but More Chronic Graft Versus Host Disease and Non-Relapse Mortality in the “Older” Patients

Dr. Peters, Peter Bader, Ulrike Pötschger, M. Akif Yesilipek, Herbert Pichler, Franco Locatelli, Raquel Staciuk, Adriana Balduzzi, Gergely Krivan, Marianne Ifversen, Cristina Díaz De Heredia, Marc Bierings, Jacek Wachowiak, Jean-Hugues Dalle

Blood (2023) 142 (Supplement 1): 3548.

https://doi.org/10.1182/blood-2023-185870

Published: 2023

Journal Articles

Impact of Donor and Patient CMV Serology in Children Receiving First Geno-Identical or Unrelated HSCT for Malignant Hematological Disease: An EBMT Retrospective Registry Study

Blood (2022) 140 (Supplement 1): 4718–4720.

https://doi.org/10.1182/blood-2022-164538

Published: 2022

Journal Articles

Long-Term Data Confirm the Superiority of Total Body Irradiation-Containing Conditioning Regimen in Comparison to a Chemotherapy-Based Preparation in Children with Acute Lymphoblastic Leukemia Above the Age of 4 Years Given an Unmanipulated Allograft. Results of the Forum Randomized Clinical Trial

Franco Locatelli, Peter Bader, Jean-Hugues Dalle, Ulrike Poetschger, Herbert Pichler, Petr Sedlacek, Jochen Büchner, Peter J. Shaw, Marianne Ifversen, Raquel Staciuk, Kim Vettenranta, Adriana Balduzzi, Christina Peters

Blood (2022) 140 (Supplement 1): 4865–4867.

https://doi.org/10.1182/blood-2022-166048

Published: 2022

Journal Articles

Outcomes of Allogeneic Hematopoietic Stem Cell Transplantation for Congenital Amegakaryocytic Thrombocytopenia, a PDWP/EBMT Study

Blood (2022) 140 (Supplement 1): 10895–10896.

https://doi.org/10.1182/blood-2022-166636

Published: 2022

Journal Articles

Relapse Is the Most Common Treatment Failure Post HSCT in Children with ALL below 4 Years of Age Given a Chemo-Based Conditioning Regimen. Results from the Prospective Multinational Forum-Trial

Christina Peters, Ulrike Poetschger, Jean-Hugues Dalle, Akif Yesilipek, Jerry Stein, Herbert Pichler, Adriana Balduzzi, Franco Locatelli, Petr Sedlacek, Jacek Wachowiak, Tayfun Güngör, Marianne Ifversen, Marleen Renard, Tony H Truong, Raquel Staciuk, Peter J. Shaw, Gergely Kriván, Jochen Büchner, Peter Bader

Blood (2022) 140 (Supplement 1): 897–899.

https://doi.org/10.1182/blood-2022-168609

Published: 2022

Journal Articles

Superior Graft-Versus-Leukemia Effect in Matched Unrelated Donor Versus HLA-Identical Sibling Pediatric Recipients Transplanted for Acute Lymphoblastic Leukemia within the Forum Study

Jean-Hugues Dalle, Peter Bader, Akif Yesilipek, Franco Locatelli, Julia Palma, Jacek Wachowiak, Herbert Pichler, Marianne Ifversen, Gergely Kriván, Jochen Buechner, Cristina Díaz-de-Heredia, Marc Bierings, Raquel Staciuk, Tayfun Gungor, Jacek Toporski, Adriana Balduzzi, Ulrike Poetschger, Christina Peters, Petr Sedlacek

Blood (2022) 140 (Supplement 1): 903–905.

https://doi.org/10.1182/blood-2022-164735

Published: 2022

Journal Articles

Hematopoietic stem cell transplantation for Wiskott-Aldrich syndrome: an EBMT Inborn Errors Working Party analysis

Blood (2022) 139 (13): 2066–2079.

https://doi.org/10.1182/blood.2021014687

Published: 2022

Includes: Supplemental data

Journal Articles

Treatment dilemmas in asymptomatic children with primary hemophagocytic lymphohistiocytosis

Blood (2018) 132 (19): 2088–2096.

https://doi.org/10.1182/blood-2018-01-827485

Published: 2018

Includes: Supplemental data

Journal Articles

Treatment Dilemmas in Asymptomatic Children with Primary Haemophagocytic Lymphohistiocytosis

Blood (2017) 130 (Supplement 1): 3564.

https://doi.org/10.1182/blood.V130.Suppl_1.3564.3564

Published: 2017

Journal Articles

Myeloablative Conditioning for First Allogeneic Hematopoietic Stem Cell Transplantation in Children with ALL: Total Body Irradiation or Chemotherapy? - a Multicenter EBMT-PDWP Study

Andre Manfred Willasch, MD, Christina Peters, MD, Petr Sedlacek, MD, Jean-Hugues Dalle, MD, Stelios Graphakos, MD, Akif Yesilipek, MD, Jacek Wachowiak, Prof MDPhD, Arjan Lankester, MD PhD, Arcangelo Prete, MD, Amir Ali Hamidieh, MD, Marianne Ifversen, Jochen Büchner, MDPhD, Gergely Krivan, MD, Rose-Marie Hamladji, MD, Cristina Diaz de Heredia, MD, Elena Skorobogatova, MD PhD, Gerard Michel, MD, Franco Locatelli, MD PhD, Alice Bertaina, MD PhD, Paul Veys, MD, Sophie Dupont, MD, Reuven Or, MD, Tayfun Guengoer, Olga Aleinikova, MD PhD, Sabina Sufliarska, MD, Mikael Sundin, MD PhD, Jelena Rascon, MD, Ain Kaare, MD, Damir Nemet, MD PhD, Franca Fagioli, MD, Thomas Klingebiel, MD, Jan Styczynski, PhD, Marc B Bierings, MDPhD, Kalman Nagy, MD, Manuel Abecasis, MD, Boris V Afanasyev, MD PhD Professor, Marc Ansari, MD, Arnaud Dalissier, Myriam Labopin, MD, Eric Beohou, Peter Bader, MD PhD

Blood (2017) 130 (Supplement 1): 911.

https://doi.org/10.1182/blood.V130.Suppl_1.911.911

Published: 2017

Journal Articles

Risk Factors Affecting Outcome of Transplantation in Pediatric Acute Lymphoblastic Leukemia: Results of the International BFM ALL SCT Study

Adriana Balduzzi, MD, Jean-Hugues Dalle, MD PhD, Arjan C Lankester, MD PhD, Isaac Yaniv, MD, Akif Yesilipek, MD, Petr Sedlacek, MD PhD, Marianne Ifversen, MD, Sabina Sufliarska, MD, Marc B Bierings, MDPhD, Jacek Wachowiak, Prof MDPhD, Jacek Toporski, MD PhD, Ulrike Poetschger, Evgenia Glogova, Ingeborg Hirsch, BS, Christina Peters, MD PhD

Blood (2015) 126 (23): 2015.

https://doi.org/10.1182/blood.V126.23.2015.2015

Published: 2015

Journal Articles

Myeloablative Chemo-Conditioning for First Hematopoietic STEM CELL Transplantation in Children with ACUTE Lymphoblastic Leukemia in First or Second Remission

Christina Peters, MD Professor of Paediatrics, Jean-Hugues Dalle, MD PhD, Stelios Graphakos, MD Assoc. Professor of Paediatric Haematology, Petr Sedlacek, Prof., MD PhD, Antonio Campos, MD, M. Akif Yesilipek, Prof. Dr., Jacek Wachowiak, MD PhD, Arjan C. Lankester, MD PhD, Andrea Pession, Amir Ali Hamidieh, MD, Marianne Ifversen, MD PhD, Jochen Büchner, MD PhD, Gergely Krivan, MD PhD, Franca Fagioli, MD, Arnaud Dalissier, Myriam Labopin, MD, Peter Bader

Blood (2014) 124 (21): 546.

https://doi.org/10.1182/blood.V124.21.546.546

Published: 2014

Journal Articles

Comparison of primary human cytotoxic T-cell and natural killer cell responses reveal similar molecular requirements for lytic granule exocytosis but differences in cytokine production

Blood (2013) 121 (8): 1345–1356.

https://doi.org/10.1182/blood-2012-07-442558

Published: 2013

Includes: Supplemental data

NARROW

Comparative Results of Pediatric Patients with ALL Receiving Either of Two Different Types of Human Anti-T Lymphocyte Globulin Prior to Hematopoietic Stem Cell Transplantation: Findings from the International Prospective Forum Study

Efficacy of T-cell assays for the diagnosis of primary defects in cytotoxic lymphocyte exocytosis

Outcomes of HLA-mismatched HSCT with TCRαβ/CD19 depletion or post-HSCT cyclophosphamide for inborn errors of immunity

Survival in primary hemophagocytic lymphohistiocytosis, 2016 to 2021: etoposide is better than its reputation

Comparable Outcome after Busulfan- or Treosulfan-Based Conditioning Regimen in Children Above 4 Years of Age with ALL Undergoing Allogeneic HSCT. Results from the Prospective International Forum-Trial

Moderate Incidence but Striking Correlation with TBI of Secondary Malignancies after HSCT in Children with ALL: Long-Term Follow-up from the Prospective International BFM- and Forum-Trials

Outcome of Children with B-Cell Precursor Acute Lymphoblastic Leukemia (BCP-ALL) with Hypodiploidy or BCR-ABL1 Fusion Given Allogeneic Hematopoietic Stem Cell Transplantation (HSCT): Results from the Prospective Forum Study

Similar Overall Survival and Event-Free Survival for Patients Under or over the Age of 14 Years, but More Chronic Graft Versus Host Disease and Non-Relapse Mortality in the “Older” Patients

Impact of Donor and Patient CMV Serology in Children Receiving First Geno-Identical or Unrelated HSCT for Malignant Hematological Disease: An EBMT Retrospective Registry Study

Long-Term Data Confirm the Superiority of Total Body Irradiation-Containing Conditioning Regimen in Comparison to a Chemotherapy-Based Preparation in Children with Acute Lymphoblastic Leukemia Above the Age of 4 Years Given an Unmanipulated Allograft. Results of the Forum Randomized Clinical Trial

Outcomes of Allogeneic Hematopoietic Stem Cell Transplantation for Congenital Amegakaryocytic Thrombocytopenia, a PDWP/EBMT Study

Relapse Is the Most Common Treatment Failure Post HSCT in Children with ALL below 4 Years of Age Given a Chemo-Based Conditioning Regimen. Results from the Prospective Multinational Forum-Trial

Superior Graft-Versus-Leukemia Effect in Matched Unrelated Donor Versus HLA-Identical Sibling Pediatric Recipients Transplanted for Acute Lymphoblastic Leukemia within the Forum Study

Hematopoietic stem cell transplantation for Wiskott-Aldrich syndrome: an EBMT Inborn Errors Working Party analysis

Treatment dilemmas in asymptomatic children with primary hemophagocytic lymphohistiocytosis

Treatment Dilemmas in Asymptomatic Children with Primary Haemophagocytic Lymphohistiocytosis

Myeloablative Conditioning for First Allogeneic Hematopoietic Stem Cell Transplantation in Children with ALL: Total Body Irradiation or Chemotherapy? - a Multicenter EBMT-PDWP Study

Risk Factors Affecting Outcome of Transplantation in Pediatric Acute Lymphoblastic Leukemia: Results of the International BFM ALL SCT Study

Myeloablative Chemo-Conditioning for First Hematopoietic STEM CELL Transplantation in Children with ACUTE Lymphoblastic Leukemia in First or Second Remission

Comparison of primary human cytotoxic T-cell and natural killer cell responses reveal similar molecular requirements for lytic granule exocytosis but differences in cytokine production

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only